2019
DOI: 10.1016/j.oooo.2019.02.113
|View full text |Cite
|
Sign up to set email alerts
|

ORAL ULCERATIONS AS THE fiRST INDICATION OF FOLATE DEfiCIENCY SECONDARY TO METHOTREXATE THERAPY

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Methotrexate (MTX) is a drug commonly used for the treatment of many forms of cancer by the way of inhibiting cancer cells from multiplying 1 . It was introduced into malignant disease treatment more than 50 years ago 2 however, its therapeutic effect is restricted by its low Blood brain barrier (BBB) permeability and poor brain targeting 3 .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Methotrexate (MTX) is a drug commonly used for the treatment of many forms of cancer by the way of inhibiting cancer cells from multiplying 1 . It was introduced into malignant disease treatment more than 50 years ago 2 however, its therapeutic effect is restricted by its low Blood brain barrier (BBB) permeability and poor brain targeting 3 .…”
Section: Introductionmentioning
confidence: 99%
“…It is considered as a basic chemotherapy drug for the treatment of brain tumors, especially leptomeningeal metastatic cancer and primary central nervous system lymphoma (PCNSL) 4 . MTX is also used to reduce inflammation in both psoriasis and rheumatoid arthritis 1 . It can enter the cells via two mechanisms active transport and passive diffusion, but active transport is the most dominant way 5 ,by the reduced folate carrier 6 .…”
Section: Introductionmentioning
confidence: 99%